[1] |
中华医学会血液学分会血栓与止血学组.易栓症诊断与防治中国指南(2021年版)[J].中华血液学杂志,2021,42(11):881-888.
|
[2] |
Zller B, Svensson PJ, Dahlbck B, et al. Genetic risk factors for venous thromboembolism [J]. Expert Rev Hematol,2020,13(9):971-981.
|
[3] |
Middeldorp S, Naue C, Khler C. Thrombophilia, thrombosis and thromboprophylaxis in pregnancy: for what and in whom? [J]. Hamostaseologie,2022,42(1):54-64.
|
[4] |
连岩,王谢桐. 遗传性易栓症的妊娠期筛查与抗凝治疗评价 [J]. 中国实用妇科与产科杂志,2017,33(7):678-684.
|
[5] |
Campello E, Spiezia L, Adamo A, et al. Thrombophilia, risk factors and prevention [J]. Expert Review of Hematology,2019,12(3):147-158.
|
[6] |
Kobayashi T, Sugiura K, Ojima T, et al. Peripartum management of hereditary thrombophilia: results of primary surveillance in Japan [J].Int J Hematol,2022,116(3):364-371.
|
[7] |
朱铁楠,赵永强,丁秋兰,等.汉族人群蛋白C,蛋白S和抗凝血酶活性水平及活性缺乏发生率的研究 [J]. 中华血液学杂志,2012,33(2):127-130.
|
[8] |
Raia-Barjat T, Edebiri O, Chauleur C. Venous thromboembolism risk score and pregnancy [J]. Frontiers in Cardiovascular Medicine,2022,9:1-8.
|
[9] |
中华医学会围产医学分会. 产科抗磷脂综合征诊断与处理专家共识 [J]. 中华围产医学杂志,2020,23(8):517-522.
|
[10] |
Szabó G, Debreceni IB, Tarr T, et al. Anti-β2-glycoprotein I autoantibodies influence thrombin generation parameters via various mechanisms [J]. Thromb Res,2021,197(5):124-131.
|
[11] |
Chaturvedi S, Braunstein EM, Yuan X,et al. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS [J]. Blood,2020,135(4):239-251.
|
[12] |
Czwalinna A, Bergmann F. Prevention of pregnancy complications in antiphospholipid syndrome [J]. Hamostaseologie,2020,40(2):174-183.
|
[13] |
Müller-Calleja N, Ritter S, Hollerbach A, et al. Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies [J]. Blood Adv,2018,2(9):979-86.
|
[14] |
Nagirnaja L, Nõmmemees D, Rull K, et al. Annexin A5 promoter haplotype M2 is not a risk factor for recurrent pregnancy loss in Northern Europe [J]. PLoS One,2015,10(7):1-15.
|
[15] |
Wirestam L, Arve S, Linge P, et al. Neutrophils—important communicators in systemic lupus erythematosus and antiphospholipid syndrome [J]. Front Immunol,2019,10:1-37.
|
[16] |
Yokote R, Kuwabara Y, Kasano S, et al. Risk factors for persistent positive anticardiolipin antibodies in women with recurrent pregnancy loss [J]. Reprod Immunol,2023,156:1-10.
|
[17] |
Voicu DI, Munteanu O, Gherghiceanu F, et al. Maternal inherited thrombophilia and pregnancy outcomes [J]. Exp Ther Med,2020,20(3):2411-2414.
|
[18] |
Simcox LE, Laura O, Clare T, et al. Thrombophilia and pregnancy complications[J]. International Journal of Molecular Sciences,2015,16(12):28418-28428.
|
[19] |
Pritchard AM, Hendrix PW, Paidas MJ. Hereditary thrombophilia and recurrent pregnancy loss [J]. Clin Obstet Gyneco,2016,59(3):487-497.
|
[20] |
Knight JS, Kanthi Y. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome [J]. Semin Immunopathol,2022,44(3):347-362.
|
[21] |
Walter IJ, Haneveld M, Lely AT, et al. Pregnancy outcome predictors in antiphospholipid syndrome: a systematic review and meta-analysis [J]. Autoimmunity Reviews,2021,20(10):1-19.
|
[22] |
Fierro JJ, Velásquez M, Cadavid AP, de Leeuw K. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome [J]. Am J Reprod Immunol,2022,87(1):1-11.
|
[23] |
Deguchi M, Yamada H, Sugiura-Ogasawara M, et al. Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: a multicenter study [J]. J Reprod Immunol,2017,122:21-27.
|
[24] |
American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy [J]. Obstet Gynecol,2018,132(1):e18-e34.
|
[25] |
董艳玲,漆洪波. ACOG "妊娠期遗传性易栓症指南(2018)"解读[J]. 中国实用妇科与产科杂志,2019,35(3):298-303.
|
[26] |
Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 37b: thromboembolic disease in pregnancy and the puerperium: acute management. 3th ed.London,2015:1-32.
|